VEGF Receptor 2 Polyclonal antibody
VEGF Receptor 2 Polyclonal Antibody for ELISA
Host / Isotype
Rabbit / IgG
Reactivity
human and More (1)
Applications
IHC, ELISA
Conjugate
Unconjugated
Cat no : 18975-1-AP
Synonyms
Validation Data Gallery
Published Applications
IHC | See 1 publications below |
Product Information
18975-1-AP targets VEGF Receptor 2 in IHC, ELISA applications and shows reactivity with human samples.
Tested Reactivity | human |
Cited Reactivity | mouse |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | Peptide |
Full Name | kinase insert domain receptor (a type III receptor tyrosine kinase) |
Calculated Molecular Weight | 152 kDa |
GenBank Accession Number | NM_002253 |
Gene Symbol | KDR |
Gene ID (NCBI) | 3791 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Antigen affinity purification |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
KDR, also named as VEGFR-2, FLK1 and CD309, is a receptor for VEGF or VEGFC. KDR which belongs to the protein kinase superfamily, has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions. KDR functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. Mutations of this gene are implicated in infantile capillary hemangiomas.
Publications
Species | Application | Title |
---|---|---|
Kidney Int TNF-mediated damage to glomerular endothelium is an important determinant of acute kidney injury in sepsis. |